Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Transaction marquante : Accueil d’une marque américaine de premier plan dans le secteur Énergie, comptant environ 8 000 personnes, afin de créer la plateforme numéro 1 dans ce secteur aux États-Unis1...
-
Milestone transaction: Welcoming a U.S. premier Power & Energy brand of approximately 8,000 people to create the #1 Power & Energy platform in the U.S.1 for a total cash purchase price of...
-
The board of directors of Probe Gold Inc. unanimously recommends that shareholders vote FOR the proposed plan of arrangement.Your vote is important no matter how many votes you hold. Vote...
-
LOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announced it has acquired WiseLayer, a New York-based company...
-
LIVERMORE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced today the acquisition of Keystone Photonics, a...
-
Evolve to commence trading on the CSE on December 17, 2025 under the ticker symbol “EVR” Not for distribution to United States newswire services or for release, publication, distribution or...
-
DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry”) today announced that, at its Special Meeting of Stockholders held earlier today, Berry stockholders voted to...
-
Advini and Cordier by InVivo Announce Their Entry into Exclusive Negotiations to Strengthen Their Position in the French Wine Industry Advini Group and Cordier by InVivo announce entry into...
-
AdVini et Cordier by InVivo annoncent leur entrée en négociations exclusives pour consolider leur position dans la filière vin française Le Groupe AdVini et Cordier by InVivo annoncent entrer en...
-
PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering...